December 3, 2018
Actelion, the global leader in the treatment of pulmonary arterial hypertension (PAH), and newest member of the Johnson & Johnson family of companies, celebrated its 20 plus year heritage of innovation in this field. As part of Pulmonary Hypertension (PH) Awareness Month, the dinner was held to celebrate Actelion’s truly ground-breaking treatments which have enabled...
Read More